Thoma Bravo Buys Mediware Information Systems for $194.6 Million
Private equity investment firm Thoma Bravo LLC has agreed to buy Mediware Information Systems Inc. (MEDW) for about $194.6 million in cash as it looks to expand its stake in the fast growing health-care technology sector.
“We see strong growth potential as more and more organizations seek technology solutions to improve the management of their clinical, regulatory and financial operations,” Thoma Bravo Managing Partner Scott Crabill said.
Under the terms of the deal, Mediware shareholders will get $22 a share, a 40% premium over the company’s Tuesday close.
The deal is expected to close by the end of the year.
Mediware makes software products that it sells to hospitals, long-term care and behavioral health facilities, blood and plasma donation centers and alternate care settings. It aims to address targeted clinical areas with suites of applications that provide clinicians a one-stop shop to manage information relating to the prescribing, preparation and administration of drug, blood and biologics therapies.
Tuesday, Mediware had reported that its per-share earnings for the second quarter climbed 16% as revenue edged up 4.3%.
Shares, which were recently halted premarket, closed at $15.75 Tuesday. The stock has climbed 41% in the past 12 months.